5N6-44216-12632
4 vaccinations
2 coded responses
26 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 12-15
- ZIP prefix
- 761 / TX
- Registered
- 2022-04-09
- Relationship
- Child or adolescent in my care
- Guardian
- ABK-22633-22940
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-15
Dose 1 — Pfizer-BioNTech
-
2021-06-05
Dose 2 — Pfizer-BioNTech
-
2022-04-08
Dose 3 — Pfizer-BioNTech
-
2022-04-09
Registered in v-safe
-
2022-04-09
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Poor · Site: Pain, Redness, Swelling · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-10
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-04-12
-
2022-04-13
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Rhinorrhoea — Feeling: GoodFree text: Nasal DrainageMedDRA releases: 2024-11 · check-in free text available
- 2022-04-15
- 2022-04-22
- 2022-05-01
- 2022-05-06
- 2022-05-13
- 2022-05-20
- 2022-07-08
- 2022-10-07
-
2022-10-14
Dose 4 — Pfizer-BioNTech
-
2022-10-14
Health check-in — day 0, dose 4, dependentFeeling: Good · Site: Pain, Swelling · NoneAdult check-in
-
2022-10-15
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-16
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-10-17
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Good · Fatigue or tirednessAdult check-in
-
2022-10-19
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Good · Fatigue or tirednessAdult check-in
-
2022-10-20
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Good · Fatigue or tirednessAdult check-in
- 2022-10-21
- 2022-10-28
- 2022-11-04
-
2022-11-11
Survey response — day 28, dose 4, dependentMedDRA: Discharge, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Upper respiratory infection with fever and congestion/drainage Took Covid test- It was NegativeMedDRA releases: 2024-11 · check-in free text available
- 2022-11-18
- 2022-11-25
- 2023-01-13
- 2023-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-15 | Pfizer-BioNTech | No |
| 2 | 2021-06-05 | Pfizer-BioNTech | No |
| 3 | 2022-04-08 | Pfizer-BioNTech | No |
| 4 | 2022-10-14 | Pfizer-BioNTech | No |
Free text
Release 11 — days 1–6 daily, dose 3, dependent
Systemic reaction (other): Nasal Drainage
Release 12 — day 28, dose 4, dependent
Symptoms: Upper respiratory infection with fever and congestion/drainage Took Covid test- It was Negative
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Discharge | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release